The concentration of serum transforming growth factor beta-1 (TGF-beta1) is decreased in cervical carcinoma patients. 2002

Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
Department of Obstetrics and Gynecology, Veterans General Hospital, Taipei, Taiwan, ROC. hswu@vghtpe.gov.tw

Transforming growth factor beta-1 (TGF-beta1) is a multifunctional growth factor and known to inhibit the proliferation of epithelial cell. The relationship between serum TGF-beta1 level and the presence of cervical cancer was investigated in this study. The patients with cervical squamous cell carcinoma (SCC) had significantly lower level of serum TGF-beta1 (39.14 +/- 9.03 ng/mL; mean +/- SD) than those with myoma (49.17 +/- 9.38 ng/mL) and normal subjects (49.13 +/- 8.81 ng/mL), (p < 0.007 and p < 0.001, respectively). TGF-beta1 level was also lower in the patients with cervical intraepithelial neoplasia (CIN3) (42.07 +/- 9.38 ng/mL) than in normal controls (49.13 +/- 8.81 ng/mL) (p < 0.04). It suggested that diminution of the production of TGF-beta1 has close association with the neoplastic transformation of cervical epithelium.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D016212 Transforming Growth Factor beta A factor synthesized in a wide variety of tissues. It acts synergistically with TGF-alpha in inducing phenotypic transformation and can also act as a negative autocrine growth factor. TGF-beta has a potential role in embryonal development, cellular differentiation, hormone secretion, and immune function. TGF-beta is found mostly as homodimer forms of separate gene products TGF-beta1, TGF-beta2 or TGF-beta3. Heterodimers composed of TGF-beta1 and 2 (TGF-beta1.2) or of TGF-beta2 and 3 (TGF-beta2.3) have been isolated. The TGF-beta proteins are synthesized as precursor proteins. Bone-Derived Transforming Growth Factor,Platelet Transforming Growth Factor,TGF-beta,Milk Growth Factor,TGFbeta,Bone Derived Transforming Growth Factor,Factor, Milk Growth,Growth Factor, Milk
D053773 Transforming Growth Factor beta1 A subtype of transforming growth factor beta that is synthesized by a wide variety of cells. It is synthesized as a precursor molecule that is cleaved to form mature TGF-beta 1 and TGF-beta1 latency-associated peptide. The association of the cleavage products results in the formation a latent protein which must be activated to bind its receptor. Defects in the gene that encodes TGF-beta1 are the cause of CAMURATI-ENGELMANN SYNDROME. TGF-beta1,Transforming Growth Factor-beta1,TGF-beta-1,TGF-beta1 Latency-Associated Protein,TGF-beta1LAP,Transforming Growth Factor beta 1 Latency Associated Peptide,Transforming Growth Factor beta I,Latency-Associated Protein, TGF-beta1,TGF beta 1,TGF beta1 Latency Associated Protein,TGF beta1LAP

Related Publications

Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
March 2000, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
February 2000, Journal of autoimmunity,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
January 2007, Progress in neuro-psychopharmacology & biological psychiatry,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
November 1998, British journal of cancer,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
June 2010, Cell biochemistry and function,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
September 1998, Journal of dental research,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
May 1997, The Journal of urology,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
April 2004, British journal of plastic surgery,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
March 2000, Developmental dynamics : an official publication of the American Association of Anatomists,
Hwa-Shyi Wu, and Ywan Feng Li, and Chuan-I Chou, and Chiou Chung Yuan, and Mei Whey Hung, and Lai Chen Tsai
May 2009, Journal of cellular physiology,
Copied contents to your clipboard!